title: [A case report of coronary artery bypass graft surgery and subsequent chemotherapy for the patient with unstable angina and small cell lung cancer].
abstract: A 74 year old female with lung cancer had undergone coronary artery bypass graft surgery (CABGS) and survived for 9 months after subsequent chemotherapy. She had been suffering from severe chest pain since 2 years before that time, and deteriorated intractably. At the same time, lung cancer was suggested radiologically, and revealed as small cell lung cancer by bronchial biopsy. Coronary angiogram study was done to verify the coronary artery disease and severe triple artery disease was shown. CABGS was done to relieve her condition to start chemotherapy. Post-operative course was fine and CODE therapy [cisplatin, oncovin (vincristine), doxorubicin (adriamycin), etoposide] was done subsequently to CABGS. Cancer focus and swollen lymph node were vanished in radiographic examination. She had discharged and spent at home for a while. However, multiple metastatic lesions emerged later, and deceased finally 9 mouths after CABGS. We conclude, CABGS done for her was a reasonable therapy to relief her condition and was successful to carry out chemotherapy.
authors.affiliation: Department of Cardiovascular Surgery, New Tokyo Hospital, Chiba.
authors.forename: A
authors.initials: A
authors.lastname: Nabuchi
authors.forename: A
authors.initials: A
authors.lastname: Amano
authors.forename: H
authors.initials: H
authors.lastname: Suma
authors.forename: F
authors.initials: F
authors.lastname: Hojo
mesh_terms: D000368:Aged; D000789:Angina, Unstable / Q000150:complications* / Q000601:surgery*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D018288:Carcinoma, Small Cell / Q000150:complications* / Q000188:drug therapy*; D002945:Cisplatin / Q000008:administration & dosage; D001026:Coronary Artery Bypass; D004317:Doxorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications* / Q000188:drug therapy*; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D014750:Vincristine; D005047:Etoposide; D004317:Doxorubicin; D002945:Cisplatin